MED1 and cardiomyopathy: Furthermore, in that study we showed that tamoxifen-inducible cardiac-specific deletion of Med1 led to the development of cardiomyopathy and death of mice within four weeks, thus underscoring the involvement of Med1 in regulating important cardiac-specific functions [14].